RVL Pharmaceuticals PLC (OTC Pink - Limited Information:RVLPQ)
| 0.0033 Delayed Data As of Dec 01 |  -0.0002 / -5.71%Today’s Change | 0.00 Today|||52-Week Range 1.58 | -99.71% Year-to-Date |
Latest RVLPQ News | Press Releases
No recent news for RVL Pharmaceuticals PLC.
Today’s Trading
| Previous close | 0.00 |
| Today’s open | 0.00 |
| Day’s range | 0.00 - 0.00 |
| Volume | 203,536 |
| Average volume (3 months) | 17,882,883 |
| Market cap | $367.6K |
Data as of 12/01/2023
Growth & Valuation
| Earnings growth (last year) | +43.80% |
| Earnings growth (this year) | +31.55% |
| Earnings growth (next 5 years) | +62.20% |
| Revenue growth (last year) | +184.10% |
| P/E ratio | -- |
| Price/Sales | 2.02 |
| Price/Book | 0.01 |
Competitors
| No competitors data available. |
Financials
| Last reporting date | November 15, 2023 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $49.7M |
| Annual profit (last year) | -$51.7M |
| Net profit margin | -103.96% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bridgewater, New Jersey |
Forecasts
Chart unavailable
